Product Information
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Accord Healthcare Inc., priced at $0.1465 per EA under NDC 16729004101. Its NADAC has been published 643 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2011. Its Orange Book therapeutic-equivalence code is BX.
Strength
.5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729004101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA091195FDA Approved
8/31/2011
TE Code
BX
On Market Since
9/30/2011
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has been published 643 times since Nov 28, 2013, and over the history we have for it it has declined 83.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1465 per EA |
|---|---|
| All-time high | $1.0399 (Feb 12, 2014) |
| All-time low | $0.1091 (Nov 20, 2024) |
| 52-week high | $0.1744 |
| 52-week low | $0.1465 |
| Median price | $0.2400 |
| Average price | $0.3299 |
| Largest weekly change | +64.8% (Sep 23, 2020) |
| Weeks tracked | 643 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-2.5%
1Y
-13.3%
3Y
-19.0%
5Y
-53.0%
All
-83.9%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Accord Healthcare Inc., is $0.1465 per EA (NDC 16729004101), effective May 20, 2026.
How has the price of TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has declined 83.9%. It has been tracked across 643 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 28, 2013, the NADAC for TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.1091 (Nov 20, 2024) to a high of $1.0399 (Feb 12, 2014), with a median of $0.2400 per EA.
Are there cheaper alternatives to TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE), is $0.1256 per EA — about 14% below TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE).
Who manufactures TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 16729004101) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.